[go: up one dir, main page]

BRPI1106311A8 - Use of mycobacterium leprae mimetic peptides for diagnosis and vaccines - Google Patents

Use of mycobacterium leprae mimetic peptides for diagnosis and vaccines

Info

Publication number
BRPI1106311A8
BRPI1106311A8 BRPI1106311A BRPI1106311A BRPI1106311A8 BR PI1106311 A8 BRPI1106311 A8 BR PI1106311A8 BR PI1106311 A BRPI1106311 A BR PI1106311A BR PI1106311 A BRPI1106311 A BR PI1106311A BR PI1106311 A8 BRPI1106311 A8 BR PI1106311A8
Authority
BR
Brazil
Prior art keywords
peptides
mycobacterium leprae
vaccines
diagnosis
mimetic peptides
Prior art date
Application number
BRPI1106311A
Other languages
Portuguese (pt)
Inventor
Ferreira De Moura Juliana
Thomaz Soccol Vanete
Original Assignee
Univ Federal Parana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Federal Parana filed Critical Univ Federal Parana
Priority to BRPI1106311A priority Critical patent/BRPI1106311A8/en
Publication of BRPI1106311A2 publication Critical patent/BRPI1106311A2/en
Publication of BRPI1106311A8 publication Critical patent/BRPI1106311A8/en

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

uso de peptídeos miméticos de mycobacterium leprae para diagnóstico e vacinas. a presente invenção relata a identificação de mimotopos de antígenos de mycobacterium leprae. os mimotopos compreendem peptídeos que apresentam utilidade em método e kit de diagnóstico. os métodos de diagnóstico são baseados na interação de tais peptídeos com componentes de amostras biológicas e posterior detecção da resultante interação. o kit de diagnóstico compreende o uso de peptídeos e reagentes de detecção da reação entre peptídeos e componentes da amostras biológicas. a invenção também se refere a composições imunológicas que contenham peptídeos como princípio ativo.use of mycobacterium leprae mimetic peptides for diagnosis and vaccines. The present invention reports the identification of mycobacterium leprae antigen mimotopes. mimotopes comprise peptides that are useful in diagnostic methods and kits. diagnostic methods are based on the interaction of such peptides with components of biological samples and subsequent detection of the resulting interaction. The diagnostic kit comprises the use of peptides and reagents for detecting the reaction between peptides and biological sample components. the invention also relates to immunological compositions that contain peptides as an active ingredient.

BRPI1106311A 2011-05-03 2011-05-03 Use of mycobacterium leprae mimetic peptides for diagnosis and vaccines BRPI1106311A8 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI1106311A BRPI1106311A8 (en) 2011-05-03 2011-05-03 Use of mycobacterium leprae mimetic peptides for diagnosis and vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI1106311A BRPI1106311A8 (en) 2011-05-03 2011-05-03 Use of mycobacterium leprae mimetic peptides for diagnosis and vaccines

Publications (2)

Publication Number Publication Date
BRPI1106311A2 BRPI1106311A2 (en) 2017-01-31
BRPI1106311A8 true BRPI1106311A8 (en) 2023-11-14

Family

ID=57890383

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1106311A BRPI1106311A8 (en) 2011-05-03 2011-05-03 Use of mycobacterium leprae mimetic peptides for diagnosis and vaccines

Country Status (1)

Country Link
BR (1) BRPI1106311A8 (en)

Also Published As

Publication number Publication date
BRPI1106311A2 (en) 2017-01-31

Similar Documents

Publication Publication Date Title
BRPI0923199B8 (en) method for determining the presence of complement-fixing antibodies
BRPI1007867B8 (en) recombinant antibody or antigen-binding fragment thereof, pharmaceutical composition and kit comprising said antibody, methods of detecting troponin i antigen in a test sample, and in vitro methods of diagnosing acute coronary syndrome or myocardial infarction in a patient
EP4249605A3 (en) Methods for analyte detection
WO2014074835A3 (en) Antibody compositions and immunoassay methods to detect isoforms of anti-mullerian hormone
BR112016004320A2 (en) biosensor, system, kit, methods for determining or identifying and quantifying an ammonia or ammonium ion concentration, diagnosing a metabolic disease in a subject, determining a patient's response to therapy, making a biosensor, of a system or any test strip and detecting the presence, absence, or amount of amino acids in a sample, and test strip
BR112014025384A8 (en) method and system for performing automated testing and methods for performing reflective testing on multiple specimens
BR112012020251A2 (en) analysis device for sample acquisition, treatment and reaction
BR112016019836A2 (en) method for analyzing a subject sample, diagnostic device for use in diagnosing endometriosis, kit, use of a biomarker, and method for increasing an antibody response in a subject
MX2013001042A (en) Pancreatic cancer biomarkers and uses thereof.
MX2016013255A (en) Methods and compositions for detecting misfolded proteins.
MX368394B (en) Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers.
MX2015012823A (en) Hcv antigen-antibody combination assay and methods and compositions for use therein.
BR112017009151A2 (en) Assays for Detecting Immune T-Cell Subgroups and Methods of Using Them
BR112013023540A2 (en) antibody, kit and method for determination of amyloid peptides
ATE514081T1 (en) T-CELL TESTING PROCEDURE
BR112013006444B8 (en) uses of coagulation composition, containers for serum sample preparation, serum sample preparation methods and analyte detection of interest
BR112015008036A2 (en) isolated peptide population, method for detecting antibody in a sample, method for diagnosing monocytic and / or granulocytic erlichiosis, and kit
MX2017009485A (en) Microfluidics based fetal cell detection and isolation for non-invasive prenatal testing.
EP2577307A4 (en) DIAGNOSTIC ASSAY
CY1123265T1 (en) AN ANALYSIS OF CELL-MEDIATED IMMUNE RESPONSE
PE20160657A1 (en) COMPOSITIONS AND METHODS TO IDENTIFY A RISK OF CANCER IN A SUBJECT
ES2684758T3 (en) Procedure to diagnose liver fibrosis
BR112014031958A2 (en) bag3 as tissue marker and biochemical serum
WO2012103337A3 (en) Assays and methods to sequence microbes directly from immune complexes
EA201370030A1 (en) BIFUNCTIONAL QUANTITATIVE IN VITRO ANALYSIS OF BINDING TARGETS FOR DETECTING NEUTRALIZING ANTIBODIES TO TARGET ANTIBODIES

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06V Preliminary requirement: patent application procedure suspended [chapter 6.22 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B03H Publication of an application: rectification [chapter 3.8 patent gazette]

Free format text: REF. AO DESPACHO 3.1 PUBLICADO NA RPI2404 DE 31/01/2017 EM RELACAO AO INID (72) INVENTOR, CONSIDEREM-SE OS DADOS ATUAIS.